Black Diamond Therapeutics, Inc. (BDTX)
1.39
-0.04
(-2.80%)
USD |
NASDAQ |
Nov 19, 16:00
1.36
-0.03
(-2.16%)
After-Hours: 07:41
Black Diamond Therapeutics Price to Book Value : 0.9069 for Nov. 19, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 19, 2026 | 0.9069 |
| November 18, 2026 | 0.933 |
| November 17, 2026 | 0.9396 |
| November 16, 2026 | 0.9983 |
| November 13, 2026 | 0.9591 |
| November 12, 2026 | 0.9918 |
| November 11, 2026 | 1.050 |
| November 10, 2026 | 1.041 |
| November 09, 2026 | 1.214 |
| November 06, 2026 | 1.132 |
| November 05, 2026 | 1.083 |
| November 04, 2026 | 1.240 |
| November 03, 2026 | 1.181 |
| November 02, 2026 | 1.142 |
| October 30, 2026 | 1.161 |
| October 29, 2026 | 1.214 |
| October 28, 2026 | 1.194 |
| October 27, 2026 | 1.142 |
| October 26, 2026 | 1.103 |
| October 23, 2026 | 1.227 |
| October 22, 2026 | 1.357 |
| October 21, 2026 | 1.357 |
| October 20, 2026 | 1.351 |
| October 19, 2026 | 1.181 |
| October 16, 2026 | 1.122 |
| Date | Value |
|---|---|
| October 15, 2026 | 1.135 |
| October 14, 2026 | 1.109 |
| October 13, 2026 | 1.096 |
| October 12, 2026 | 1.155 |
| October 09, 2026 | 1.194 |
| October 08, 2026 | 1.181 |
| October 07, 2026 | 1.194 |
| October 06, 2026 | 1.174 |
| October 05, 2026 | 1.266 |
| October 02, 2026 | 1.233 |
| October 01, 2026 | 1.227 |
| September 30, 2026 | 1.230 |
| September 29, 2026 | 1.118 |
| September 28, 2026 | 1.094 |
| September 25, 2026 | 1.124 |
| September 24, 2026 | 1.130 |
| September 23, 2026 | 1.136 |
| September 22, 2026 | 1.184 |
| September 21, 2026 | 1.166 |
| September 18, 2026 | 1.172 |
| September 17, 2026 | 1.154 |
| September 16, 2026 | 1.160 |
| September 15, 2026 | 1.178 |
| September 14, 2026 | 1.214 |
| September 11, 2026 | 1.184 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Lineage Cell Therapeutics, Inc. | 3.092 |
| Armata Pharmaceuticals, Inc. | -- |
| Voyager Therapeutics, Inc. | 0.7409 |
| Invivyd, Inc. | 0.876 |
| Elicio Therapeutics, Inc. | 2.252 |
Price to Book Value Related Metrics
| Price | 1.39 |
| Earnings Yield | -55.37% |
| Market Cap | 79.88M |